Brain Talk: Brain Talk Podcast
View All Brain Talk Podcasts

Finding a Cure for ALS
Jeffrey Rothstein, M.D., Ph.D.
Professor, Departments of Neurology and Neuroscience
The John W. Griffin M.D. Director for Johns Hopkins Brain Science Institute
Director, Packard Center for ALS Research

Dr. Rothsteins Bio:Dr. Jeff Rothstein

Dr. Rothsten is the John W. Griffin Director for the Brain Science Institute, as well as a Professor of Neurology and Neuroscience, and the Founding Director of the Robert Packard Center for ALS Research at Johns Hopkins University School of Medicine. In 1977, he received his undergraduate degree in Neuroscience from Colgate University, followed by his Master’s degree in Neurochemistry-Biopsychology from the University of Chicago in 1979. Dr. Rothstein continued his graduate education at the University of Illinois College of Medicine and Health Sciences Center to receive his Doctorate in Physiology and Biophysics-Neurochemistry in 1984, as well as his Medical degree in 1985. His clinical training included an internship at the University of North Carolina Memorial Hospital, followed by his Neurology Residency at Johns Hopkins Hospital. After completing his residency in 1989, he continued his medical education at Johns Hopkins through a Neuromuscular Fellowship. In 1991, Dr. Rothstein accepted a position as Assistant Professor in the Department of Neurology at Johns Hopkins University, which he held until 1994 when he was promoted to Associate Professor of Neurology, with additional appointments in the Graduate Training Program in Cellular and Molecular Medicine, as well as the Department of Neuroscience. In 2000, in addition to being promoted to his current position as Professor of Neurology and Neuroscience, Dr. Rothstein became the Director and Founder of the Robert Packard Center for ALS Research, which has uses philanthropic dollars to support the most promising researchers around the world  to work collaboratively to develop models of ALS and to ALS therapies. In 2011, he also accepted his current position as Director of the Johns Hopkins Brain Science Institute (BSi).

A respected and internationally renowned neuroscientist, Dr. Rothstein is credited as being one of the world’s top ALS researchers and has over 25 years as a clinician scientist studying ALS pathophysiology, astrocyte biology and therapy discovery; it was his research on ALS pathogenesis that lead to the first successful, FDA-approved drug to alter neurodegeneration in ALS. In addition to running a basic science lab and an ALS clinic at Johns Hopkins which evaluates and manages over 350 ALS patients every year, the BSi also runs a drug discovery group consisting of 25 medicinal chemists to identify novel therapeutics for neurological and psychiatric disease. Learn more about Dr. Rothstein
 

Additional Information:

Visit the Robert Packard Center for ALS Research at Johns Hopkins’ website

CNN's Series on ALS with Dr. Rothstein

Northeast Amyotrophic Lateral Sclerosis Consotrium (NEALS)

ALS Association
 

 
Share This Information